The slower recovery PSA screening rate in Black men highlights the persistent racial disparities in health care access. In this analysis, the model performed best for predicting survival Asian patients and worst for Non-Hispanic Black patients. Hispanic men who are Black or Cuban had the lowest rates of prostate-specific antigen screening. Race-associated tumor differences can affect early diagnostic testing and targeted therapeutics. Only half of patients received timely follow-up, and 34% received no follow-up at all.